GLOBAL BIO-CHEM TECHNOLOGY GROUP COMPANY LIMITED Financials Global Bio-chem Technology Group Company Limited
Equities
809
KYG3919S1057
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.102 HKD | +0.99% |
|
-0.97% | -3.77% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 313.6 | 1,152 | 3,340 | 1,105 | 1,390 | 944.2 |
| Enterprise Value (EV) 1 | 9,534 | 10,232 | 12,767 | 10,124 | 10,204 | 6,261 |
| P/E ratio | -0.26 x | -0.96 x | -1.31 x | -2.76 x | -0.96 x | 0.36 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.06 x | 0.25 x | 3.93 x | 1.48 x | 3.73 x | 0.69 x |
| EV / Revenue | 1.69 x | 2.24 x | 15 x | 13.6 x | 27.4 x | 4.56 x |
| EV / EBITDA | -18.2 x | -50.5 x | -48.8 x | -16.8 x | -17.9 x | -20.9 x |
| EV / FCF | -368 x | 95.1 x | 28.7 x | -75.7 x | -273 x | -3.78 x |
| FCF Yield | -0.27% | 1.05% | 3.49% | -1.32% | -0.37% | -26.4% |
| Price to Book | -0.09 x | -0.27 x | -0.57 x | -0.17 x | -0.18 x | -0.23 x |
| Nbr of stocks (in thousands) | 6,398,998 | 7,678,798 | 8,907,406 | 8,907,406 | 8,907,406 | 8,907,406 |
| Reference price 2 | 0.0490 | 0.1500 | 0.3750 | 0.1240 | 0.1560 | 0.1060 |
| Announcement Date | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 | 4/24/24 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 5,658 | 4,561 | 848.9 | 746.6 | 372.3 | 1,374 |
| EBITDA 1 | -524.7 | -202.4 | -261.6 | -604 | -569.5 | -299.8 |
| EBIT 1 | -1,005 | -681.8 | -693.3 | -982.3 | -877.9 | -582.8 |
| Operating Margin | -17.76% | -14.95% | -81.68% | -131.58% | -235.81% | -42.42% |
| Earnings before Tax (EBT) 1 | -1,367 | -1,077 | -2,411 | -409.5 | -1,574 | 3,701 |
| Net income 1 | -1,222 | -1,068 | -2,430 | -400.8 | -1,443 | 4,225 |
| Net margin | -21.6% | -23.41% | -286.26% | -53.69% | -387.63% | 307.48% |
| EPS 2 | -0.1910 | -0.1555 | -0.2860 | -0.0450 | -0.1620 | 0.2907 |
| Free Cash Flow 1 | -25.89 | 107.6 | 445.5 | -133.8 | -37.34 | -1,655 |
| FCF margin | -0.46% | 2.36% | 52.48% | -17.92% | -10.03% | -120.48% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 | 4/24/24 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 9,221 | 9,081 | 9,426 | 9,019 | 8,815 | 5,317 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -17.57 x | -44.86 x | -36.04 x | -14.93 x | -15.48 x | -17.73 x |
| Free Cash Flow 1 | -25.9 | 108 | 445 | -134 | -37.3 | -1,655 |
| ROE (net income / shareholders' equity) | 43% | 28.2% | 47% | 6.85% | 21% | -63.3% |
| ROA (Net income/ Total Assets) | -6.1% | -4.72% | -5.47% | -8.72% | -8.9% | -6.59% |
| Assets 1 | 20,031 | 22,629 | 44,403 | 4,597 | 16,218 | -64,128 |
| Book Value Per Share 2 | -0.5400 | -0.5500 | -0.6600 | -0.7300 | -0.8500 | -0.4500 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0200 | 0 | 0 | 0.0100 |
| Capex 1 | 145 | 51.4 | 16.8 | 25.8 | 6.18 | 43.8 |
| Capex / Sales | 2.55% | 1.13% | 1.98% | 3.46% | 1.66% | 3.19% |
| Announcement Date | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 | 4/24/24 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.77% | 116M | |
| -2.00% | 277B | |
| -5.38% | 91.92B | |
| -4.35% | 42.95B | |
| +0.75% | 41.25B | |
| +6.11% | 40.01B | |
| +5.54% | 38.81B | |
| -13.54% | 30.87B | |
| -11.43% | 27.21B | |
| +7.73% | 24.19B |
- Stock Market
- Equities
- 809 Stock
- Financials Global Bio-chem Technology Group Company Limited
